Transurethral resection of the prostate immediately after high-intensity focused ultrasound treatment for prostate cancer

International Journal of Urology

Volumn 17, Issue 11, 2010, Pages 924-930

  Sumitomo, Makoto ^a   Asakuma, Junichi ^a   Sato, Akinori ^a   Ito, Keiichi ^a   Nagakura, Kazuhiko ^b   Asano, Tomohiko ^a  

^a Department of Urology   (United Kingdom)

^b Department of Urology   (Japan)

Author keywords

High intensity focused ultrasound; Prostate cancer; Transurethral resection of the prostate; Urinary complication

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CATHETERIZATION; BLADDER OBSTRUCTION; CONTRACTURE; CONTROLLED STUDY; EPIDIDYMITIS; FOLLOW UP; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE CANCER; RECTOURETHRAL FISTULA; RETROSPECTIVE STUDY; STRESS INCONTINENCE; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; ULTRASOUND TRANSDUCER; URETHRA FISTULA; URETHRA STRICTURE; URINE RETENTION;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; HUMANS; JAPAN; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TIME FACTORS; TRANSURETHRAL RESECTION OF PROSTATE; TREATMENT OUTCOME; ULTRASOUND, HIGH-INTENSITY FOCUSED, TRANSRECTAL; URETHRAL STRICTURE; URINATION DISORDERS;

EID: 77958552196     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2010.02638.x     Document Type: Article

References (20)

1. Poissonnier L, Chapelon JY, Rouviere O et al. Control of prostate cancer by transrectal HIFU in 227 patients. Eur. Urol. 2007; 51: 381-7.
2. Blana A, Murat FJ, Walter B et al. First analysis of the long-term results with transrectal HIFU in patients with localised prostate cancer. Eur. Urol. 2008; 53: 1194-201.
3. Chaussy C, Thuroff S. The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection. Curr. Urol. Rep. 2003; 4: 248-52.
4. Blana A, Hierl J, Rogenhofer S et al. Factors predicting for formation of bladder outlet obstruction after high-intensity focused ultrasound in treatment of localized prostate cancer. Urology 2008; 71: 863-7.
5. Vallancien G, Prapotnich D, Cathelineau X, Baumert H, Rozet F. Transrectal focused ultrasound combined with transurethral resection of the prostate for the treatment of localized prostate cancer: feasibility study. J. Urol. 2004; 171: 2265-7.
6. Uchida T, Sanghvi NT, Gardner TA et al. Transrectal high-intensity focused ultrasound for treatment of patients with stage T1b-2n0m0 localized prostate cancer: a preliminary report. Urology 2002; 59: 394-8; discussion 398-9.
7. American Joint Committee on Cancer. Prostate. In: Greene FL, Page DL, Fleming ID et al. (eds). AJCC Cancer Staging Manual. Springer, New York, 2002; 337-45.
8. Otsuki H, Sumitomo M, Umeda S et al. [Transurethral resection of prostate just following high intensity focused ultrasound in localized prostate cancer - trial for early removal of the urethral catheter]. Hinyokika Kiyo 2008; 54: 189-95.
9. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822-30.
10. Rhoden EL, Teloken C, Sogari PR, Vargas Souto CA. The use of the simplified International Index of Erectile Function (IIEF-5) as a diagnostic tool to study the prevalence of erectile dysfunction. Int. J. Impot. Res. 2002; 14: 245-50.
11. Roach M III, Hanks G, Thames H Jr et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int. J. Radiat. Oncol. Biol. Phys. 2006; 65: 965-74.
12. Madersbacher S, Pedevilla M, Vingers L, Susani M, Marberger M. Effect of high-intensity focused ultrasound on human prostate cancer in vivo. Cancer Res. 1995; 55: 3346-51.
13. Gelet A, Chapelon JY, Bouvier R et al. Treatment of prostate cancer with transrectal focused ultrasound: early clinical experience. Eur. Urol. 1996; 29: 174-83.
14. Rebillard X, Gelet A, Davin JL et al. Transrectal high-intensity focused ultrasound in the treatment of localized prostate cancer. J. Endourol. 2005; 19: 693-701.
15. Uchida T, Shoji S, Nakano M et al. Transrectal high-intensity focused ultrasound for the treatment of localized prostate cancer: eight-year experience. Int. J. Urol. 2009; 16: 881-6.
16. Heung YM, Walsh K, Sriprasad S, Mulvin D, Sherwood RA. The detection of prostate cells by the reverse transcription-polymerase chain reaction in the circulation of patients undergoing transurethral resection of the prostate. BJU Int. 2000; 85: 65-9.
17. Stott SL, Lee RJ, Nagrath S et al. Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer. Sci. Transl. Med. 2010; 2: 25ra23.
18. McVary K. Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology. BJU Int. 2006; 97 (Suppl 2): 23-8; discussion 44-5.
19. Lehrer S, Cesaretti J, Stone NN, Stock RG. Urinary symptom flare after brachytherapy for prostate cancer is associated with erectile dysfunction and more urinary symptoms before implantation. BJU Int. 2006; 98: 979-81.
20. Ahmed HU, Zacharakis E, Dudderidge T et al. High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series. Br. J. Cancer 2009; 101: 19-26.